
Metlip 23.75mg Tablet ER
Marketer
Zorion Drugs & Herbs Pvt. Ltd.
Salt Composition
Metoprolol Succinate (23.75mg)
Overview Metlip 23.75mg Tablet ER
CardioBeta 23.75mg Extended-Release Tablets are classified as beta-adrenergic blockers. This medication treats hypertension (high blood pressure), angina pectoris (chest pain from heart conditions), and cardiac arrhythmias (irregular heartbeats). It's also used for migraine prevention and reducing the risk of future strokes and heart attacks. CardioBeta 23.75mg ER may be prescribed alone or in combination with other drugs. Dosage and frequency depend on your specific condition and its severity. Take it consistently at the same time each day, with or without food, for optimal effectiveness. Full therapeutic benefits may take several weeks to manifest, and continued use, even when feeling well, is crucial for maintaining blood pressure control. Discontinuing the medication can exacerbate your condition. Common side effects, usually mild and transient, include fatigue, headache, depressive mood, diarrhea, skin rashes, bradycardia (slow heart rate), dizziness, and nausea. Less frequently, shortness of breath or hypotension (low blood pressure) may occur. To minimize side effects, your physician will likely initiate treatment with a low dose, gradually increasing it as needed. Report any persistent or bothersome side effects to your doctor. Inform your physician of any liver impairment before commencing treatment. This medication may be unsuitable for individuals with bradycardia, severe peripheral vascular disease, severe congestive heart failure, or hypotension. Pregnant or lactating individuals require medical consultation prior to use. Always seek your doctor's advice to determine suitability and ensure regular blood pressure monitoring to assess treatment effectiveness. Alcohol consumption should be limited due to the potential for increased side effects.
Uses of Metlip 23.75mg Tablet ER
Managing angina pectoris (chest pain from heart issues) | Correcting cardiac arrhythmias | Reducing heart attack risk | Hypertension (high blood pressure) management | Migraine prophylaxis
Major Benefits of Metlip 23.75mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Metlip 23.75mg Extended-Release tablet whole; do not crush, chew, or break it. While it can be taken with or without food, consistent timing is recommended. Limit consumption of high-fat foods like olive oil, nuts (including Brazil nuts), dark chocolate, butter, and red meat when taking Metlip 23.75mg Tablet ER.
Common Side effects of Metlip 23.75mg Tablet ER:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Metlip 23.75mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Metlip 23.75mg Extended-Release Tablets. Ingest the tablet whole; do not crush, chew, or break it. While this medication can be taken with or without food, consistent timing is recommended. Limit consumption of high-fat foods, including olive oil, nuts (especially Brazil nuts), dark chocolate, butter, and red meat, while using Metlip 23.75mg ER tablets.
How Metlip 23.75mg Tablet ER works:
Cardio-Met ER 23.75mg tablets provide extended-release beta-blockade, targeting cardiac function. This medication reduces heart rate and enhances the heart's pumping efficiency, improving circulatory function.
SAFETY ADVICE
AlcoholUNSAFE
Combining Metlip 23.75mg Extended-Release Tablets with alcohol is not advisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Metlip 23.75mg tablets might pose pregnancy risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Metlip 23.75mg tablets are likely safe for use while breastfeeding. Available human data indicate minimal risk to the infant.
DrivingUNSAFE
Extended-release Metlip 23.75mg tablets can cause drowsiness, blurred vision, and dizziness. Driving is discouraged if these effects are experienced.
KidneySAFE IF PRESCRIBED
Extended-release Metlip tablets (23.75 mg) are considered safe for individuals with kidney impairment. No dosage modification is advised for Metlip 23.75 mg extended-release tablets in such patients.
LiverCAUTION
Patients with liver impairment should exercise caution when using Metlip 23.75mg Extended-Release tablets. Dosage modification of Metlip 23.75mg Extended-Release tablets may be necessary; physician consultation is advised.
What if you forget to take Metlip 23.75mg Tablet ER :
Should you forget to take a Metlip 23.75mg Extended-Release Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metlip 23.75mg Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Alcohols and Phenols |
| Developing Habits | No. |
| Treatment Category | Heart |
